In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Nathalie VanlaerDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0000-0003-0108-6611 Camille TestaferrataDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0009-0005-1136-7689 Lynn DecabooterDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0009-0003-1374-3196 Iris DirvenDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0000-0003-2168-0781 Cleo BertelsDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0009-0000-7096-476X Lara StasCore Facility, Support for Quantitative and Qualitative Research (SQUARE), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.ORCID 0000-0003-1567-2881 Sebastien Van EyckenDepartment of Psychiatry, Centre Hospitalier Universitaire Brugmann, 1020 Brussels, Belgium.
Matthieu HeinDepartment of Psychiatry, Centre Hospitalier Universitaire Brugmann, 1020 Brussels, Belgium.ORCID 0000-0003-4243-1653 Bart NeynsDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0000-0003-0658-5903 Anne RogiersDepartment of Medical Oncology, Vrije Universiteit Brussel (VUB), Translational Oncological Research Centre, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.ORCID 0000-0003-3716-2559 Funding
Research Foundation - Flanders 11N9425N
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancer-related cognitive impairmentcancer survivorscognitioncognitive complaintsintegrativeinterventionmultidisciplinarypsychological distresspsycho-oncologysurvivorship
Identifiers
PMID41827720
PMCPMC12984640
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390